![Carl F. Mauch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl F. Mauch
Investor Relations Kontakt bei TCR2 THERAPEUTICS INC.
Profil
Carl F.
Mauch currently works at Stern Investor Relations, Inc., as Director from 2016, TCR2 Therapeutics, Inc., as Investor Relations & Media Contact, and iTeos Therapeutics, Inc., as Investor Relations & Media Contact.
Aktive Positionen von Carl F. Mauch
Unternehmen | Position | Beginn |
---|---|---|
TCR2 THERAPEUTICS INC. | Investor Relations Kontakt | - |
ITEOS THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Stern Investor Relations, Inc.
![]() Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.01.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ITEOS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Stern Investor Relations, Inc.
![]() Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
TCR2 Therapeutics, Inc.
![]() TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |